Dr Zonghai Li
Dr. Zonghai Li Founder, CEO and CSO of CARsgen Therapeutics, a leading company on CAR-T cell therapeutics in China.
Dr. Li is a professor and principal investigator in Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine. Dr. Li got his M.D. and Ph.D. from Hunan Medical University and Fudan University respectively. Dr. Li is dedicated to developing innovative immune therapeutics to fight cancer. He has advanced several first-in-class CAR-T cell therapeutics for the treatment of patients with pancreatic, gastric, liver cancer and other cancer types.